Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, reflects on her highlights from the European Group for Blood and Marrow Transplantation (EBMT) 2023 meeting, emphasizing the focus placed on hot topics such as the prophylaxis and treatment of graft-versus-host disease (GvHD) as well as the exploration of novel treatment strategies such as gene therapy in non-malignant disorders. This interview took place at the 49th Annual EBMT Meeting held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.